After 12 weeks , PAC-QOL overall score and satisfaction subscale score significantly ( p < 0.001 ) improved by 1 point ( clinically relevant ) in 36.5 % and 44.1 % of patients treated with prucalopride , compared with 18.5 % and 22.4 % with placebo respectively .